Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

BACKGROUND: The efficacy and safety of capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer (mCRC) considered unsuitable for receiving first-line chemotherapy with an irinotecan or oxaliplatin-based combination were assessed in a phase II, open, multicentre, uncontrolle...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Feliu, J, Safont, M J, Salud, A, Losa, F, García-Girón, C, Bosch, C, Escudero, P, López, R, Madroñal, C, Bolaños, M, Gil, M, Llombart, A, Castro-Carpeño, J, González-Barón, M
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2010
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2869164/
https://ncbi.nlm.nih.gov/pubmed/20424611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605663
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires